Variant position: 345 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 617 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human SRYLRLEVHYHNPLVIEGRN DSSGIRLYYTAKLRRFNAGIM
Mouse SPFLRLEVHYHNPRKIQGRQ DSSGIRLHYTATLRRYDAGIM
Rat SRFLRLEVHYHNPRNIQGRR DSSGIRLHYTASLRPNEAGIM
Bovine SRFLRLEVHYHNPLVITGRR DSSGIRLYYTAALRRFDAGIM
Horse SRFLRLEVHYHNPLKIEGRR DSSGIRLYYTATLRRFDAGIM
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 617 Dopamine beta-hydroxylase
40 – 617 Soluble dopamine beta-hydroxylase
38 – 617 Intragranular
333 – 333 Copper A
154 – 596
Mutations in the dopamine beta-hydroxylase gene are associated with human norepinephrine deficiency.
Kim C.-H.; Zabetian C.P.; Cubells J.F.; Cho S.; Biaggioni I.; Cohen B.M.; Robertson D.; Kim K.-S.;
Am. J. Med. Genet. 108:140-147(2002)
Cited for: VARIANTS ORTHYP1 MET-101; GLU-114 AND ASN-345;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.